Linagliptin (CAS 668270-12-0): A Cornerstone in Modern Diabetes Treatment
NINGBO INNO PHARMCHEM CO.,LTD. is proud to announce its robust supply of high-quality Linagliptin, a pivotal active pharmaceutical ingredient (API) recognized for its efficacy in managing Type 2 Diabetes Mellitus. As a leading manufacturer and supplier of pharmaceutical raw materials, NINGBO INNO PHARMCHEM CO.,LTD. ensures that its Linagliptin meets the most stringent global standards, providing a reliable source for pharmaceutical companies worldwide.
Linagliptin, identified by its CAS Registry Number 668270-12-0, is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor. Its mechanism of action involves preventing the breakdown of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By maintaining higher levels of these hormones, Linagliptin helps to stimulate insulin release in a glucose-dependent manner and suppress glucagon secretion, ultimately leading to improved glycemic control in patients. This targeted approach minimizes the risk of hypoglycemia, making it a preferred choice in antidiabetic therapies.
Our Linagliptin raw material is characterized by its molecular formula C25H28N8O2 and a molecular weight of 472.54. It presents as a fine white powder with an assay of no less than 99%, ensuring high purity and consistent performance in downstream manufacturing processes. NINGBO INNO PHARMCHEM CO.,LTD. adheres strictly to GMP guidelines throughout the production process, from sourcing raw materials to final packaging, guaranteeing product integrity and safety. Our commitment to quality is unwavering, reflecting in every batch of Linagliptin supplied.
The global demand for effective antidiabetic treatments continues to grow, driven by the increasing prevalence of diabetes. Linagliptin plays a crucial role in addressing this health challenge, offering a well-tolerated and effective therapeutic option. Pharmaceutical formulators can rely on our Linagliptin powder for various applications, including the development of tablets and other solid oral dosage forms. Its stability and high purity make it an ideal starting material for complex drug syntheses, ensuring the consistent quality of the final drug product.
NINGBO INNO PHARMCHEM CO.,LTD. understands the critical need for a dependable manufacturer and supplier of high-quality pharmaceutical raw materials. We are committed to providing competitive price options for bulk purchase of Linagliptin, supporting the cost-effective production of essential medicines. Our dedicated team is ready to assist with inquiries regarding product specifications, lead times, and shipping logistics. For those looking to buy premium Linagliptin (CAS 668270-12-0) powder, NINGBO INNO PHARMCHEM CO.,LTD. is your trusted partner. We offer prompt delivery and exceptional customer service, ensuring a seamless procurement experience for your pharmaceutical manufacturing needs. Partner with us for your Linagliptin requirements and contribute to better health outcomes globally.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.